Decoy Therapeutics Inc. (DCOY)
Nasdaq: DCOY · Pharmaceutical Preparations · Houston, TX · filing with the SEC since 2014
Filings
388 filings since 2017 beside 166 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by May 15, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Aug 4, 2026.
Filings a yearinsider forms included
8785396733427346
2026 counts to Nov 13, 2026.
Listing warning from its exchange (8-K item 3.01): 4 times in the last 36 months, the newest Jan 2, 2026.Officer or director change (8-K item 5.02): 5 times in the last 36 months, the newest Nov 19, 2025.SEC letters: 11 in the last 36 months, the newest Aug 11, 2025.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Sep 23, 2026
8-K items 1.01, 3.02, 7.01, 9.01
Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD) · Current report
Sep 22, 2026
Jun 29, 2026
8-K items 1.01, 3.02, 7.01, 9.01
Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD) · Current report
Jun 26, 2026
Mar 5, 2026
8-K items 3.03, 5.03, 8.01, 9.01
Change to shareholders' rights; Charter, bylaw or fiscal-year change; Other event · Current report
Jan 8, 2026
8-K items 5.03, 8.01, 9.01
Charter, bylaw or fiscal-year change; Other event · Current report
Dec 19, 2025
8-K items 5.07, 7.01, 9.01
Shareholder vote; Investor disclosure (Regulation FD) · Current report
40 of 388 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.